Aligos Therapeutics (ALGS) Revenue (2019 - 2026)
Aligos Therapeutics (ALGS) posted Revenue of $2.83 million for Q1 2026, up 810.0% from $311,000 a year earlier.
Powered by 
Analysis
Aligos Therapeutics (ALGS) Revenue (2019 - 2026) Analysis & Trends
For FY2025, Aligos Therapeutics' Revenue came in at $2.19 million, down 39.5% from FY2024.
- Annual Revenue has declined for three consecutive years, with a four-year compound annual growth rate of -15.8% (FY2021 to FY2025).
- In prior years, Aligos Therapeutics' Revenue was $3.61 million in FY2024 (-61.3%), $9.34 million in FY2023 (-32.9%), $13.91 million in FY2022 (+219.0%) and $4.36 million in FY2021.
- The Q1 2026 figure stands as the highest quarterly Revenue since Q2 2023.
- On a year-over-year basis, Revenue increased in 1 of the last eight quarters, with growth averaging 55.7%.
- The strongest year-over-year quarter for Revenue in the past five years was Q4 2022, with growth of 863.8%; the weakest was Q2 2024, with a decline of 75.3%.
- According to Business Quant data, Revenue for the three prior quarters was $169,000 (Q4 2025), $741,000 (Q3 2025) and $965,000 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.19 Bn | 1,101.77 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 616.03 Bn | 534.56 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 366.82 Bn | 321.20 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 297.82 Bn | 261.81 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.33 Bn | 235.02 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 235.89 Bn | 191.29 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 190.64 Bn | 164.84 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 169.32 Bn | 115.96 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Aligos Therapeutics | 52.78 Mn | -275.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2.83 Mn |
| Dec 31, 2025 | 169,000.00 |
| Sep 30, 2025 | 741,000.00 |
| Jun 30, 2025 | 965,000.00 |
| Mar 31, 2025 | 311,000.00 |
| Dec 31, 2024 | 606,000.00 |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 1.06 Mn |
| Mar 31, 2024 | 694,000.00 |
| Dec 31, 2023 | 2.01 Mn |
| Sep 30, 2023 | 2.15 Mn |
| Jun 30, 2023 | 4.29 Mn |
| Mar 31, 2023 | 2.58 Mn |
| Dec 31, 2022 | 3.54 Mn |
| Sep 30, 2022 | 4.11 Mn |
| Jun 30, 2022 | 3.69 Mn |
| Mar 31, 2022 | 2.57 Mn |
| Dec 31, 2021 | 367,000.00 |
| Sep 30, 2021 | 1.54 Mn |
| Jun 30, 2021 | 1.55 Mn |
API Access
Aligos Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ALGS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();